Grifols and Egypt inaugurate first plasma-supply platform in Africa

Read more

Grifols invests in Biotest to increase patient access to plasma therapies

Read more
 
 
COVID-19 COVID-19

Grifols is a global company that since 1909 has enhanced the health and well-being of people around the world. Our four divisions - Bioscience, Diagnostic, Hospital, and Bio Supplies - develop, produce, and market innovative solutions and services in more than 100 countries.

Grifols Grifols
Find out more about Grifols' International Headquarters
Select your continent
  • Africa
  • America
  • Asia
  • Europe
  • Oceania
Select your country / region
  • Australia
  • New Zealand
Select your country / region
  • Andorra
  • Austria
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Gibraltar
  • Iceland
  • Ireland
  • Italy
  • Norway
  • Poland
  • Portugal
  • San Marino
  • Slovak Republic
  • Spain
  • Spain (Headquarters)
  • Sweden
  • Switzerland
  • United Kingdom
  • Vaticano
Select your country / region
  • Argentina
  • Aruba
  • Bolivia
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Costa Rica
  • Curacao
  • Dominican Republic
  • Ecuador
  • El Salvador
  • Guatemala
  • Honduras
  • Mexico
  • Nicaragua
  • Panama
  • Paraguay
  • Peru
  • Surinam
  • Trinidad and Tobago
  • USA
  • Uruguay
  • Venezuela
Select your country / region
  • Bahrain
  • Bangladesh
  • Brunei
  • Cambodia
  • China
  • Dubai (United Arab Emirates)
  • Hong Kong SAR
  • India
  • Indonesia
  • Iraq
  • Japan
  • Jordan
  • Kuwait
  • Laos
  • Lebanon
  • Malaysia
  • Oman
  • Pakistan
  • Philippines
  • Qatar
  • Saudi Arabia
  • Singapore (Asia Pacific)
  • South Korea
  • Sri Lanka
  • Taiwan, China
  • Thailand
  • Vietnam
  • Yemen
 
Select your country / region
  • Angola
  • Cape Verde
  • Egypt
  • Guinea-Bissau
  • Mozambique
  • São Tomé and Príncipe